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The regenerative potential of endothelial progenitor cell (EPC)-based therapies is
limited due to poor cell viability and minimal retention following application.
Neovascularization can be improved by means of scaffolds supporting EPCs. The aim
of the present study was to investigate whether human early EPCs (eEPCs) could be
efficiently cultured on pharmacologically active microcarriers (PAMs), made with
poly(d,l-lactic-coglycolic acid) and coated with adhesion/extracellular matrix
molecules. They may serve as a support for stem cells and may be used as cell
carriers providing a controlled delivery of active protein such as the angiogenic
factor, vascular endothelial growth factor-A (VEGF-A). eEPC adhesion to fibronectin-
coated PAMs (FN-PAMs) was assessed by means of microscopic evaluation and by
means of Alamar blue assay. Phospho ERK(1/2) and PARP-1 expression was
measured by means of Western blot to assess the survival effects of FN-PAMs
releasing VEGF-A (FN-VEGF-PAMs). The Alamar blue assay or a modified Boyden
chamber assay was employed to assess proliferative or migratory capacity,
respectively. Our data indicate that eEPCs were able to adhere to empty FN-PAMs
within a few hours. FN-VEGF-PAMs increased the ability of eEPCs to adhere to them
and strongly supported endothelial-like phenotype and cell survival. Moreover, the
release of VEGF-A by FN-PAMs stimulated in vitro HUVEC migration and
proliferation. These data strongly support the use of PAMs for supporting eEPC
growth and survival and for stimulating resident mature human endothelial cells.
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